Bibliography
- Schmid H. Peginesatide for the treatment of renal disease-induced anemia. Exp Opin Pharmacother 2013;14:937-48
- Fan Q, Leuther KK, Holmes CP, et al. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp Hematol 2006;34:1303-11
- Macdougall IC, Provenzano R, Sharma A, et al. PEARL Study Groups. Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. N Engl J Med 2013;368:320-32
- Fishbane S, Schiller B, Locatelli F, et al. EMERALD Study Groups. Peginesatide in patients with anemia undergoing hemodialysis. N Engl J Med 2013;368:307-19
- Available from: http://omontys.com/ [Last viewed on 26 February 2013]
- Available from: http://medicalxpress.com/news/2013-02-fda-omontys.html [Viewed on 26 February 2013]
- Fineberg SE, Galloway JA, Fineberg NS, et al. Immunogenicity of recombinant DNA human insulin. Diabetologia 1983;25:465-9
- Matsuda F, Torii Y, Enomoto H, et al. Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C. J Viral Hepat 2012;19:694-703
- Jungedal R, Lundkvist M, Engdahl E, et al. Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice. Mult Scler 2012;18:1775-81
- Fan Q, Leuther KK, Holmes CP, et al. Preclinical evaluation of hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp Hematol 2006;34:1303-11
- Woodburn KW, Schatz PJ, Fong KL, Beaumier P. Erythropoiesis equivalence, pharmacokinetics and immune response following repeat hematide administration in cynomolgus monkeys. Int J Immunopathol Pharmacol 2010;23(1):121-9
- Macdougall IC, Rossert J, Casadevall N, et al. A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med 2009;361:1848-55
- Hoffman JM, Li E, Doloresco F, et al. Projecting future drug expenditures–2012. Am J Health Syst Pharm 2012;69:405-21
- Woodburn KW, Wilson SD, Fong KL, et al. Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeys. Haematologica 2008;93:1376-9
- Siscovick DS, Sotoodehnia N, Rea TD, et al. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord 2010;11:53-9